ROCHESTER, N.Y., Oct. 30 /PRNewswire-FirstCall/ -- VirtualScopics, Inc. , a leading developer of image-based biomarker solutions, announced today that they will be presenting at two upcoming investor conferences. Jeff Markin, president and CEO, will present a corporate overview and highlight VirtualScopics' recent developments at the C.E. Unterberg, Towbin Life Sciences Conference at 4:30 p.m. EST, on October 31, 2006 at the New York Palace Hotel in New York City. On the same day at 9:15 a.m. EST, Molly Henderson, CFO, will also be presenting a company overview and highlights at the Western New York Investors Conference at the Buffalo-Niagara Marriott Hotel in Amherst, New York.
A live Web cast of Markin's presentation will be available in the "Investor Relations" section of the company's Web site at http://www.virtualscopics.com. The Web cast will be archived for 90 days.
About VirtualScopics, Inc.
VirtualScopics, Inc. is a leading provider of imaging solutions to accelerate drug and medical device development. VirtualScopics has developed a robust software platform for analysis and modeling of both structural and functional medical images. In combination with VirtualScopics' industry- leading experience and expertise in advanced imaging biomarker measurement, this platform provides a uniquely clear window into the biological activity of drugs and devices in clinical trial patients, allowing sponsors to make better decisions faster. For more information about VirtualScopics, visit http://www.virtualscopics.com.
Forward-Looking Statements
The statements contained in this press release that are not purely historical are forward-looking statements within the meaning of Section 27A of the Securities Act of 1933, as amended and Section 21E of the Securities Exchange Act of 1934, as amended, and are intended to be covered by the safe harbors created thereby. Forward-looking statements deal with the Company's current plans, intentions, beliefs and expectations. Investors are cautioned that all forward-looking statements involve risks and uncertainties that could cause actual results to differ materially from those in the forward-looking statements. Factors that could cause or contribute to such differences include, but are not limited to, those discussed from time to time in reports filed by the Company with the Securities and Exchange Commission.
CONTACT: Tracy Bagatelle-Black Bagatelle-Black Public Relations 661/263-1842 tracy@bagatelleblack.com Tim Ryan Trout Group Investor Relations 212 477-9007 x24 tryan@troutgroup.com
VirtualScopics, Inc.CONTACT: Tracy Bagatelle-Black of Bagatelle-Black Public Relations,+1-661-263-1842, or tracy@bagatelleblack.com; or Tim Ryan of Trout GroupInvestor Relations, +1-212-477-9007 x24, or tryan@troutgroup.com, both forVirtualScopics, Inc.
Web site: http://www.virtualscopics.com//
